01 11GILEAD SCIENCES INC
02 2JANSSEN PRODS
01 139296769
01 13Y
01 13Y
01 132032-08-15
Patent Expiration Date : 2032-08-15
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208215
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208215
Patent Use Code : U-1259
Delist Requested :
Patent Use Description : PROPHYLAXIS OF HIV-1 I...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208464
Patent Use Code : U-999
Delist Requested :
Patent Use Description : TREATMENT OF CHRONIC H...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
EMTRICITABINE; RILPIVIRINE HYDROCHLORIDE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208351
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208215
Patent Use Code : U-1663
Delist Requested :
Patent Use Description : TREATMENT OF HIV-1 INF...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208464
Patent Use Code : U-1275
Delist Requested :
Patent Use Description : TREATMENT OF CHRONIC H...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
COBICISTAT; ELVITEGRAVIR; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 207561
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208464
Patent Use Code : U-3880
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208215
Patent Use Code : U-1663
Delist Requested :
Patent Use Description : TREATMENT OF HIV-1 INF...
Patent Expiration Date : 2032-08-15
Patent Expiration Date : 2032-08-15
BICTEGRAVIR SODIUM; EMTRICITABINE; TENOFOVIR ALAFENAMIDE FUMARATE
US Patent Number : 9296769
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 210251
Patent Use Code : U-257
Delist Requested :
Patent Use Description : TREATMENT OF HIV INFEC...
Patent Expiration Date : 2032-08-15
